Folic acid deficiency: Main etiological
β
Ainur Akilzhanova; Noboru Takamura; Kiyoshi Aoyagi; Ludmila Karazhanova; Shunich
π
Article
π
2006
π
John Wiley and Sons
π
English
β 285 KB
## Induction Chemotherapy and Post-Remission Imatinib Therapy for de Novo BCR-ABL-Positive AML To the Editor: Translocation t(9;22)(q34;q11) is found in 1-2% of newly diagnosed patients with de novo AML. The prognosis of Ph ΓΎ AML is very poor with a median survival time of only 7 months. We presen